Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Management of negative symptoms among patients with schizophrenia attending multiple-family groups.

Dyck DG, Short RA, Hendryx MS, Norell D, Myers M, Patterson T, McDonell MG, Voss WD, McFarlane WR.

Psychiatr Serv. 2000 Apr;51(4):513-9.

PMID:
10737828
2.

Service use among patients with schizophrenia in psychoeducational multiple-family group treatment.

Dyck DG, Hendryx MS, Short RA, Voss WD, McFarlane WR.

Psychiatr Serv. 2002 Jun;53(6):749-54.

PMID:
12045314
3.

A program for relapse prevention in schizophrenia: a controlled study.

Herz MI, Lamberti JS, Mintz J, Scott R, O'Dell SP, McCartan L, Nix G.

Arch Gen Psychiatry. 2000 Mar;57(3):277-83.

PMID:
10711914
4.

Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients.

Hogarty GE, Greenwald D, Ulrich RF, Kornblith SJ, DiBarry AL, Cooley S, Carter M, Flesher S.

Am J Psychiatry. 1997 Nov;154(11):1514-24.

PMID:
9356558
5.
6.

Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study.

Girón M, Fernández-Yañez A, Mañá-Alvarenga S, Molina-Habas A, Nolasco A, Gómez-Beneyto M.

Psychol Med. 2010 Jan;40(1):73-84. doi: 10.1017/S0033291709006126. Epub 2009 Jun 3.

PMID:
19490746
7.

Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE).

Crawford MJ, Killaspy H, Barnes TR, Barrett B, Byford S, Clayton K, Dinsmore J, Floyd S, Hoadley A, Johnson T, Kalaitzaki E, King M, Leurent B, Maratos A, O'Neill FA, Osborn D, Patterson S, Soteriou T, Tyrer P, Waller D; MATISSE project team..

Health Technol Assess. 2012;16(8):iii-iv, 1-76. doi: 10.3310/hta16080.

8.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

9.

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.

Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O'Brien R, Schofield N, McGovern J.

Am J Psychiatry. 2001 Oct;158(10):1706-13.

PMID:
11579006
10.

Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.

Grant PM, Huh GA, Perivoliotis D, Stolar NM, Beck AT.

Arch Gen Psychiatry. 2012 Feb;69(2):121-7. doi: 10.1001/archgenpsychiatry.2011.129. Epub 2011 Oct 3.

PMID:
21969420
11.

Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.

Health Technol Assess. 2001;5(21):1-75. Review.

12.

Multiple-family groups and psychoeducation in the treatment of schizophrenia.

McFarlane WR, Lukens E, Link B, Dushay R, Deakins SA, Newmark M, Dunne EJ, Horen B, Toran J.

Arch Gen Psychiatry. 1995 Aug;52(8):679-87.

PMID:
7632121
13.

High-yield cognitive behavioral techniques for psychosis delivered by case managers to their clients with persistent psychotic symptoms: an exploratory trial.

Turkington D, Munetz M, Pelton J, Montesano V, Sivec H, Nausheen B, Kingdon D.

J Nerv Ment Dis. 2014 Jan;202(1):30-4. doi: 10.1097/NMD.0000000000000070.

14.
15.

Early intervention for psychosis.

Marshall M, Rathbone J.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004718. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD004718.

PMID:
17054213
16.

Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.

Bobes J, Arango C, Garcia-Garcia M, Rejas J; CLAMORS Study Collaborative Group..

J Clin Psychiatry. 2010 Mar;71(3):280-6. doi: 10.4088/JCP.08m04250yel. Epub 2009 Nov 3. Erratum in: J Clin Psychiatry. 2011 Jul;72(7):1017.

PMID:
19895779
17.

Multiple-family group treatment for English- and Vietnamese-speaking families living with schizophrenia.

Bradley GM, Couchman GM, Perlesz A, Nguyen AT, Singh B, Riess C.

Psychiatr Serv. 2006 Apr;57(4):521-30.

PMID:
16603748
19.

Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.

Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R.

Arch Gen Psychiatry. 2004 Sep;61(9):866-76.

PMID:
15351765
20.

Integrated family and individual therapy for bipolar disorder: results of a treatment development study.

Miklowitz DJ, Richards JA, George EL, Frank E, Suddath RL, Powell KB, Sacher JA.

J Clin Psychiatry. 2003 Feb;64(2):182-91.

PMID:
12633127

Supplemental Content

Support Center